Eucrates Biomedical Acquisition Corp. (EUCR)

NASDAQ: EUCR · IEX Real-Time Price · USD
9.92
+0.05 (0.51%)
Dec 5, 2022 1:50 PM EST - Market closed
0.51%
Market Cap 41.51M
Revenue (ttm) n/a
Net Income (ttm) 2.53M
Shares Out 13.46M
EPS (ttm) 0.19
PE Ratio 52.21
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,226
Open 9.9
Previous Close 9.87
Day's Range 9.9 - 9.92
52-Week Range 9.75 - 10.07
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About EUCR

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York. [Read more]

Industry Blank Check / SPAC
IPO Date Oct 23, 2020
Employees 4
Stock Exchange NASDAQ
Ticker Symbol EUCR
Full Company Profile

Financial Performance

Financial Statements

News

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

NEW YORK, June 1, 2021 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exc...

1 year ago - PRNewsWire

Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering

NEW YORK, Oct. 27, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset a...

2 years ago - PRNewsWire

Eucrates Biomedical Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

NEW YORK, Oct. 23, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset a...

2 years ago - PRNewsWire